Axon Regeneration After Schwann Cell Graft to Injured Spinal Cord
Topic: Spinal Cord Injury (SCI)
Author: Cell Transplantation Center of Excellence for Aging and Brain Repair
Published: 2013/12/27 - Updated: 2021/09/23
Contents: Summary - Introduction - Main - Related
Synopsis: Researchers reveal properties of a spinal cord/Schwann cell bridge interface enable regenerated and elongated brainstem axons to cross the bridge and potentially lead to an improvement in hind limb movement of rats with spinal cord injury. Elongation of astrocyte processes across transplant interfaces likely establishes three-dimensional structures that determine how regenerating axons become exposed to myriad growth-promoting and inhibitory cues. We demonstrated that the elongation of astrocyte processes into SC transplants, and the formation of NG2+ tunnels, enables brainstem axon regeneration and improvement in function.
Introduction
A study carried out at the University of Miami Miller School of Medicine for "The Miami Project to Cure Paralysis" has found that transplanting self-donated Schwann cells (SCs, the principal en-sheathing cells of the nervous system) that are elongated so as to bridge scar tissue in the injured spinal cord, aids hind limb functional recovery in rats modeled with spinal cord injury.
Main Digest
"Injury to the spinal cord results in scar and cavity formation at the lesion site," explains study corresponding author Dr. Mary Bartlett Bunge of the University of Miami Miller School of Medicine. "Although numerous cell transplantation strategies have been developed to nullify the lesion environment, scar tissue - in basil lamina sheets - wall off the lesion to prevent further injury and, also, at the interface, scar tissue impedes axon regeneration into and out of the grafts, limiting functional recovery."
The researchers determined that the properties of a spinal cord/Schwann cell bridge interface enable regenerated and elongated brainstem axons to cross the bridge and potentially lead to an improvement in hind limb movement of rats with spinal cord injury.
Electron microscopy revealed that axons, SCs, and astrocytes were enclosed together within tunnels bounded by continuous basal lamina. The expression of neuroglycan (NG2; a proteoglycan found on the membrane of cells) was associated with these tunnels. They subsequently determined that a "trio" of astrocyte processes, SCs and regenerating axons were "bundled" together within the tunnels of basal lamina.
"Elongation of astrocyte processes across transplant interfaces likely establishes three-dimensional structures that determine how regenerating axons become exposed to myriad growth-promoting and inhibitory cues," wrote the researchers. The researchers also noted that it was important to understand conditions that favor astrocytes to be permissive for axonal growth into lesion transplants.
"We demonstrated that the elongation of astrocyte processes into SC transplants, and the formation of NG2+ tunnels, enables brainstem axon regeneration and improvement in function," they concluded. "This study supports the clinical use of SCs for SCI repair and defines important characteristics of permissive spinal cord/graft interfaces."
"Developing the means to bridge the glial scar following chronic spinal cord injury is one of the major stumbling blocks of therapy" said Dr. John Sladek, Cell Transplantation section editor and professor of neurology and pediatrics at the University of Colorado School of Medicine. "This study provides important new insight into how this may be achieved".
Citations:
The study is published in Cell Transplantation.
Williams, R. R.; Henao, M.; Pearse, D. D.; Bunge, M. B. Permissive Schwann Cell Graft/Spinal Cord Interfaces For Axon Regeneration. Cell Transplant. Appeared or available online: October 22, 2013. The Coeditors-in-chief for CELL TRANSPLANTATION are at the Diabetes Research Institute, University of Miami Miller School of Medicine and Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact, Camillo Ricordi, MD at ricordi@miami.edu or Shinn-Zong Lin, MD, PhD at shinnzong@yahoo.com.tw or David Eve, PhD at celltransplantation@gmail.com
Attribution/Source(s):
This quality-reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Cell Transplantation Center of Excellence for Aging and Brain Repair, and published on 2013/12/27 (Edit Update: 2021/09/23), the content may have been edited for style, clarity, or brevity. For further details or clarifications, Cell Transplantation Center of Excellence for Aging and Brain Repair can be contacted at Dr. Mary Bartlett Bunge, The Miami Project to Cure Paralysis, Lois Pope Life Center. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Cell Transplantation Center of Excellence for Aging and Brain Repair. (2013, December 27 - Last revised: 2021, September 23). Axon Regeneration After Schwann Cell Graft to Injured Spinal Cord. Disabled World. Retrieved September 12, 2024 from www.disabled-world.com/disability/types/spinal/schwann-cell.php
Permalink: <a href="https://www.disabled-world.com/disability/types/spinal/schwann-cell.php">Axon Regeneration After Schwann Cell Graft to Injured Spinal Cord</a>: Researchers reveal properties of a spinal cord/Schwann cell bridge interface enable regenerated and elongated brainstem axons to cross the bridge and potentially lead to an improvement in hind limb movement of rats with spinal cord injury.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.